Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_assertion type Assertion NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_head.
- NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_assertion description "[We reasoned that the anti-inflammatory actions of mesenchymal stromal cells (MSCs) and further antitumor effects of MSCs engineered to overexpress tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein (MSC-TRAIL) would effectively inhibit mesothelioma growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_provenance.
- NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_assertion evidence source_evidence_literature NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_provenance.
- NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_assertion SIO_000772 25525034 NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_provenance.
- NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_assertion wasDerivedFrom befree-2016 NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_provenance.
- NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_assertion wasGeneratedBy ECO_0000203 NP1249607.RAItV19LTM24fUqnNIGuB00K_fljnoNw3rcYUc3acSi5Y130_provenance.